Arrowhead Pharmaceuticals (ARWR) Tax Provisions (2021 - 2026)
Arrowhead Pharmaceuticals' (ARWR) quarterly Tax Provisions came in at $7000.0 in Q1 2026, down 99.6% YoY from $1.8 million in Q1 2025, and down 75.86% on a QoQ basis from $29000.0 in Q4 2025.
Arrowhead Pharmaceuticals (ARWR) Tax Provisions (2021 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals (ARWR) has 6 years of Tax Provisions data on file, last reported at $7000.0 in Q1 2026.
- Quarterly Tax Provisions fell 99.6% year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (up 721.93% YoY) and the FY2025 annual result came in at $21.4 million, up 874.09% from the prior year.
- Tax Provisions fell to $7000.0 in Q1 2026, from $29000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $20.0 million in Q3 2025 to a low of -$3.3 million in Q4 2023.
- A 5-year average of $2.3 million and a median of $533000.0 in 2024 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions jumped 189150.0% — and 2026, when it plunged 99.6%.
- Tracing ARWR's Tax Provisions over 5 years: stood at $3.8 million in 2022, then slumped by 187.53% to -$3.3 million in 2023, then surged by 103.11% to $103000.0 in 2024, then sank by 71.84% to $29000.0 in 2025, then plunged by 75.86% to $7000.0 in 2026.
- The last three Tax Provisions figures came in at $7000.0 (Q1 2026), $29000.0 (Q4 2025), and $20.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Arrowhead Pharmaceuticals | 12.23 Bn | 10.63 Bn | - | 11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 20.00 Mn |
| Jun 30, 2025 | -400,000.00 |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | 103,000.00 |
| Sep 30, 2024 | 533,000.00 |
| Dec 31, 2023 | -3.31 Mn |
| Sep 30, 2023 | 2.03 Mn |
| Jun 30, 2023 | 742,000.00 |
| Sep 30, 2022 | 3.79 Mn |
| Sep 30, 2021 | 2,000.00 |